ATC code R03
ATC code R03 Drugs for obstructive airway diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup R03 is part of the anatomical group R Respiratory system.[4]
| ATC code R: Respiratory system |
|---|
|
| Other ATC codes |
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QR03.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
R03A Adrenergics, inhalants
R03AA Alpha- and beta-adrenoreceptor agonists
- R03AA01 Epinephrine
R03AB Non-selective beta-adrenoreceptor agonists
- R03AB02 Isoprenaline
- R03AB03 Orciprenaline
R03AC Selective beta-2-adrenoreceptor agonists
- R03AC02 Salbutamol
- R03AC03 Terbutaline
- R03AC04 Fenoterol
- R03AC05 Rimiterol
- R03AC06 Hexoprenaline
- R03AC07 Isoetarine
- R03AC08 Pirbuterol
- R03AC09 Tretoquinol
- R03AC10 Carbuterol
- R03AC11 Tulobuterol
- R03AC12 Salmeterol
- R03AC13 Formoterol
- R03AC14 Clenbuterol
- R03AC15 Reproterol
- R03AC16 Procaterol
- R03AC17 Bitolterol
- R03AC18 Indacaterol
- R03AC19 Olodaterol
R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
- R03AK01 Epinephrine and other drugs for obstructive airway diseases
- R03AK02 Isoprenaline and other drugs for obstructive airway diseases
- R03AK04 Salbutamol and sodium cromoglicate
- R03AK05 Reproterol and sodium cromoglicate
- R03AK06 Salmeterol and fluticasone
- R03AK07 Formoterol and budesonide
- R03AK08 Formoterol and beclometasone
- R03AK09 Formoterol and mometasone
- R03AK10 Vilanterol and fluticasone furoate
- R03AK11 Formoterol and fluticasone
- R03AK12 Salmeterol and budesonide
- R03AK13 Salbutamol and beclometasone
- R03AK14 Indacaterol and mometasone
R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
- R03AL01 Fenoterol and ipratropium bromide
- R03AL02 Salbutamol and ipratropium bromide
- R03AL03 Vilanterol and umeclidinium bromide
- R03AL04 Indacaterol and glycopyrronium bromide
- R03AL05 Formoterol and aclidinium bromide
- R03AL06 Olodaterol and tiotropium bromide
- R03AL07 Formoterol and glycopyrronium bromide
- R03AL08 Vilanterol, umeclidinium bromide, and fluticasone furoate
- R03AL09 Formoterol, glycopyrronium bromide and beclometasone
- R03AL10 Formoterol and tiotropium bromide
- R03AL11 Formoterol, glycopyrronium bromide, and budesonide
- R03AL12 Indacaterol, glycopyrronium bromide and mometasone
R03B Other drugs for obstructive airway diseases, inhalants
R03BA Glucocorticoids
- R03BA01 Beclometasone
- R03BA02 Budesonide
- R03BA03 Flunisolide
- R03BA04 Betamethasone
- R03BA05 Fluticasone
- R03BA06 Triamcinolone
- R03BA07 Mometasone
- R03BA08 Ciclesonide
- R03BA09 Fluticasone furoate
R03BB Anticholinergics
- R03BB01 Ipratropium bromide
- R03BB02 Oxitropium bromide
- R03BB03 Stramoni preparations
- R03BB04 Tiotropium bromide
- R03BB05 Aclidinium bromide
- R03BB06 Glycopyrronium bromide
- R03BB07 Umeclidinium bromide
- R03BB08 Revefenacin
- R03BB54 Tiotropium bromide, combinations
R03BC Antiallergic agents, excluding corticosteroids
- R03BC01 Cromoglicic acid
- R03BC03 Nedocromil
R03BX Other drugs for obstructive airway diseases, inhalants
- R03BX01 Fenspiride
R03C Adrenergics for systemic use
R03CA Alpha- and beta-adrenoreceptor agonists
- R03CA02 Ephedrine
R03CB Non-selective beta-adrenoreceptor agonists
- R03CB01 Isoprenaline
- R03CB02 Methoxyphenamine
- R03CB03 Orciprenaline
- R03CB51 Isoprenaline, combinations
- R03CB53 Orciprenaline, combinations
R03CC Selective beta-2-adrenoreceptor agonists
- R03CC02 Salbutamol
- R03CC03 Terbutaline
- R03CC04 Fenoterol
- R03CC05 Hexoprenaline
- R03CC06 Isoetarine
- R03CC07 Pirbuterol
- R03CC08 Procaterol
- R03CC09 Tretoquinol
- R03CC10 Carbuterol
- R03CC11 Tulobuterol
- R03CC12 Bambuterol
- R03CC13 Clenbuterol
- R03CC14 Reproterol
- R03CC15 Formoterol
- R03CC53 Terbutaline, combinations
- R03CC63 Clenbuterol and ambroxol
- QR03CC90 Clenbuterol, combinations
R03D Other systemic drugs for obstructive airway diseases
R03DA Xanthines
- R03DA01 Diprophylline
- R03DA02 Choline theophyllinate
- R03DA03 Proxyphylline
- R03DA04 Theophylline
- R03DA05 Aminophylline
- R03DA06 Etamiphylline
- R03DA07 Theobromine
- R03DA08 Bamifylline
- R03DA09 Acefylline piperazine
- R03DA10 Bufylline
- R03DA11 Doxofylline
- R03DA12 Mepyramine theophyllinacetate
- R03DA20 Combinations of xanthines
- R03DA51 Diprophylline, combinations
- R03DA54 Theophylline, combinations excluding psycholeptics
- R03DA55 Aminophylline, combinations
- R03DA57 Theobromine, combinations
- R03DA74 Theophylline, combinations with psycholeptics
R03DB Xanthines and adrenergics
- R03DB01 Diprophylline and adrenergics
- R03DB02 Choline theophyllinate and adrenergics
- R03DB03 Proxyphylline and adrenergics
- R03DB04 Theophylline and adrenergics
- R03DB05 Aminophylline and adrenergics
- R03DB06 Etamiphylline and adrenergics
R03DC Leukotriene receptor antagonists
- R03DC01 Zafirlukast
- R03DC02 Pranlukast
- R03DC03 Montelukast
- R03DC04 Ibudilast
- R03DC53 Montelukast, combinations
R03DX Other systemic drugs for obstructive airway diseases
- R03DX01 Amlexanox
- R03DX02 Eprozinol
- R03DX03 Fenspiride
- R03DX05 Omalizumab
- R03DX06 Seratrodast
- R03DX07 Roflumilast
- R03DX08 Reslizumab
- R03DX09 Mepolizumab
- R03DX10 Benralizumab
- R03DX11 Tezepelumab
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code R03". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QR03". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.